1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America ECMO Market – By Modality

1.3.2        North America ECMO Market – By Application

1.3.3        North America ECMO Market – By Age Group

1.3.4        North America ECMO Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America ECMO Market – Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Experts Opinion

5.           North America ECMO Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Cardiovascular Diseases and Respiratory Failures

5.1.2        Growing Adoption of ECMO in Lung Transplantation Procedures

5.2         Market Restraints

5.2.1        Complications Associated with ECMO

5.3         Market Opportunities

5.3.1        Increasing Survival Rates with ECMO

5.4         Future Trends

5.4.1        Surging Product Developments and Approvals

5.5         Impact Analysis

6.           ECMO Market – North America Analysis

6.1         North America ECMO Market Revenue Forecast & Analysis

7.           North America ECMO Market Analysis – By Modality

7.1         Overview

7.2         North America ECMO Market Share by Modality 2021 & 2028 (%)

7.3         Venoarterial ECMO

7.3.1        Overview

7.3.2        Venoarterial ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)

7.4         Venovenous ECMO

7.4.1        Overview

7.4.2        Venovenous ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)

7.5         Arteriovenous ECMO

7.5.1        Overview

7.5.2        Arteriovenous ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)

8.           North America ECMO Market Analysis – By Application

8.1         Overview

8.2         North America ECMO Market, By Application 2021 & 2028 (%)

8.3         Cardiology

8.3.1        Overview

8.3.2        Cardiology Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Respiratory

8.4.1        Overview

8.4.2        Respiratory Market Revenue and Forecast to 2028 (US$ Mn)

9.           North America ECMO Market Analysis – By Age Group

9.1         Overview

9.2         North America ECMO Market, By Age Group 2021 & 2028 (%)

9.3         Neonates

9.3.1        Overview

9.3.2        Neonates Market Revenue and Forecast to 2028 (US$ Mn)

9.4         Pediatrics

9.4.1        Overview

9.4.2        Pediatrics Market Revenue and Forecast to 2028 (US$ Mn)

9.5         Adults

9.5.1        Overview

9.5.2        Adults Market Revenue and Forecast to 2028 (US$ Mn)

10.        North America ECMO Market – Country Analysis

10.1      Overview

10.1.2     North America: ECMO Market, by Country, 2021 & 2028 (%)

10.1.2.1       US: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1       Overview

10.1.2.1.2       US: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.3       US: ECMO Market, by Modality, 2020–2028 (US$ Million)

10.1.2.1.4       US: ECMO Market, by Application, 2020–2028 (US$ Million)

10.1.2.1.5       US: ECMO Market, by Age Group, 2020–2028 (US$ Million)

10.1.2.2       Canada: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.1       Overview

10.1.2.2.2       Canada: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.3       Canada: ECMO Market, by Modality, 2020–2028 (US$ Million)

10.1.2.2.4       Canada: ECMO Market, by Application, 2020–2028 (US$ Million)

10.1.2.2.5       Canada: ECMO Market, by Age Group, 2020–2028 (US$ Million)

10.1.2.3       Mexico: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1       Overview

10.1.2.3.2       Mexico: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.3       Mexico: ECMO Market, by Modality, 2020–2028 (US$ Million)

10.1.2.3.4       Mexico: ECMO Market, by Application, 2020–2028 (US$ Million)

10.1.2.3.5       Mexico: ECMO Market, by Age Group, 2020–2028 (US$ Million)

11.        Industry Landscape

11.1      Overview

11.2      Inorganic Growth Strategies

11.2.1     Overview

11.3      Organic Growth Strategies

11.3.1     Overview

12.        Company Profiles

12.1      Terumo Group

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Medtronic Plc

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      MicroPort Scientific Corporation

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      LivaNova Plc

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Nipro Medical Corporation

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Eurosets S.R.L.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Getinge AB

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Braile Biomedica

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Fresenius Medical Care AG & Co KGaA

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   ABIOMED Inc

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America ECMO Market – Revenue and Forecast to 2028 (US$ Million)

Table 2.             US ECMO Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 3.             US ECMO Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 4.             US ECMO Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 5.             Canada ECMO Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Canada ECMO Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 7.             Canada ECMO Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 8.             Mexico ECMO Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Mexico ECMO Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 10.          Mexico ECMO Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 11.          Recent Inorganic Growth Strategies

Table 12.          Recent Organic Growth Strategies

Table 13.          Glossary of Terms

LIST OF FIGURES

Figure 1.           North America ECMO Market Segmentation

Figure 2.           North America ECMO Market, By Country

Figure 3.           North America ECMO Market Overview

Figure 4.           North America ECMO Market, By Modality

Figure 5.           North America ECMO Market, By Country

Figure 7.           North America: PEST Analysis

Figure 8.           Experts Opinion

Figure 9.           Impact Analysis: North America ECMO Market

Figure 10.        North America ECMO Market – Revenue Forecast and Analysis

Figure 11.        North America ECMO Market Share by Modality 2021 & 2028 (%)

Figure 12.        Venoarterial ECMO: North America ECMO Market Revenue and Forecast To 2028 (US$ Million)

Figure 13.        Venovenous ECMO: North America ECMO Market Revenue and Forecast To 2028 (US$ Million)

Figure 14.        Arteriovenous ECMO: North America ECMO Market Revenue and Forecast To 2028 (US$ Million)

Figure 15.        North America ECMO Market, by Application 2021 & 2028 (%)

Figure 16.        Cardiology : North America ECMO Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        Respiratory : North America ECMO Market Revenue and Forecasts To 2028 (US$ MN)

Figure 18.        North America ECMO Market, by Age Group 2021 & 2028 (%)

Figure 19.        Neonates : North America ECMO Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20.        Pediatrics : North America ECMO Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21.        Adults : North America ECMO Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22.        North America: ECMO Market, by Key Country – Revenue (2021) (US$ Million)

Figure 23.        North America: ECMO Market, by Country, 2021 & 2028 (%)

Figure 24.        US: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Canada: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.          Mexico: ECMO Market – Revenue and Forecast to 2028 (US$ Million)